4 reports

Chinese private company SinoMab Bioscience is developing this antibody and has conducted at least two clinical phase I studies, one in non-Hodkgin lymphoma (NHL) (Li, 2012) and one in systemic lupus erythematosus (SLE) (Zhao, 2016).

  • Lymphoma
  • United States
  • AstraZeneca PLC
  • Immunomedics, Inc.
  • Pfizer Inc.

Antibody Cancer ## ## ID No.

  • Lymphoma
  • Biogen Idec Inc.
  • Boehringer Ingelheim GmbH
  • Celltrion, Inc.
  • Genentech, Inc.

II DIFFUSE LARGE BCELL LYMPHOMA (DLBCL).

  • Lymphoma
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • United States

Seattle Genetics PR Feb ##, 2016 - The company announced initiation of a phase ## clinical trial of SGN- CD##B for relapsed or refractory patients with two subtypes of B-cell non-Hodgkin lymphoma (NHL): diffuse large B-cell lymphoma (DLBCL) and grade ## follicular lymphoma.

  • Biopharmaceutical
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Xencor, Inc.